{"id":1068345,"date":"2022-11-05T01:42:23","date_gmt":"2022-11-05T05:42:23","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/pmv-pharmaceuticals-appoints-industry-veteran-dr-carol-gallagher-to-board-of-directors\/"},"modified":"2024-08-18T11:46:07","modified_gmt":"2024-08-18T15:46:07","slug":"pmv-pharmaceuticals-appoints-industry-veteran-dr-carol-gallagher-to-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/pmv-pharmaceuticals-appoints-industry-veteran-dr-carol-gallagher-to-board-of-directors.php","title":{"rendered":"PMV Pharmaceuticals Appoints Industry Veteran Dr. Carol Gallagher to Board of Directors"},"content":{"rendered":"<p><![CDATA[CRANBURY, N.J., Nov.  04, 2022  (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc.\u00a0(Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced the appointment of Carol Gallagher, Pharm.D., to its Board of Directors. Dr. Gallagher brings more than 30 years of biotech leadership and expertise in drug development and commercialization. She replaces Thilo Schroeder, Ph.D., who is stepping down from the Board. The Board changes are effective immediately.]]><\/p>\n<p>Visit link:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/11\/04\/2548706\/0\/en\/PMV-Pharmaceuticals-Appoints-Industry-Veteran-Dr-Carol-Gallagher-to-Board-of-Directors.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"PMV Pharmaceuticals Appoints Industry Veteran Dr. Carol Gallagher to Board of Directors\">PMV Pharmaceuticals Appoints Industry Veteran Dr. Carol Gallagher to Board of Directors<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Visit link: PMV Pharmaceuticals Appoints Industry Veteran Dr. Carol Gallagher to Board of Directors <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/pmv-pharmaceuticals-appoints-industry-veteran-dr-carol-gallagher-to-board-of-directors.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068345","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068345"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068345"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068345\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}